Sheba’s doctors evaluate each patient to determine who is a suitable candidate for CAR T-cell therapy.
Potential patients need to have undergone at least two leukemia treatments in the past.
Currently, we provide this innovative treatment for the following diseases:
- Acute Lymphocytic Leukemia (ALL), Adult
- Non-Hodgkin’s Lymphoma (NHL), Adult and Pediatric
- Leukemia (ALL), Pediatric
- Multiple Myeloma
- Acute Myelogenous Leukemia (AML)